Compounds effective as β2-adrenoreceptor agonists as...

Details Compounds effective as β2-adrenoreceptor agonists as... Compounds effective as β2-adrenoreceptor agonists as...

2005-08-23

2005-08-23

McKenzie, Thomas C. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S248000, C514S252040, C544S230000, C544S237000, C544S238000, C544S239000

Reexamination Certificate

active

06933296

ABSTRACT:
The compounds of formula I in which Ar1, A, R6, R7, R8 and Ar2have the meanings as given in the description are novel effective bronchial therapeutics

REFERENCES:
patent: 0 030 835 (1981-06-01), None
patent: 0 763 534 (1997-03-01), None
patent: 0 934 933 (1999-08-01), None
patent: 58146571 (1983-09-01), None
patent: 164079 (1994-06-01), None
patent: 94/12461 (1994-06-01), None
patent: 98/31674 (1998-07-01), None
patent: 98/37894 (1998-09-01), None
patent: 99/31071 (1999-06-01), None
patent: 99/31090 (1999-06-01), None
patent: 00/12078 (2000-03-01), None
Shire, M.G. et al, Exp. Opin. Ther. Patents, 8, 1998, 531-544.
He, W. et al, J. Med. Chem., 41, 1998, 4216-4223.
Duplantier, A.J. et al, J. Med. Chem., May, 1998, vol. 41, No. 13, pp. 2268-2277.
Doherty, A.M., Current Opinion Chemical Biology, 1999, 3, 466-473.
West, Anthony R., Solid State Chemistry and its Application, Wiley, New York, 1988, pp. 358 & 365.
Giembycz, M.A.Drugs Feb. 2000, vol. 59, No. 2, pp. 193-212.
David J.W. Grant, “University of Minnesota—Twin Cities Campus College of Pharmacy, Annual Report”, [online] 1999, [retrieved on Feb. 13, 2003]. Retrieved from the internet, <http://www.msi.umn.edu/general/Reports/ar99/departments/pharmacy.html>.
Burnouf, et al. “Chapter 10: Phosphodiesterases 4 Inhibitors”, Section II—Cardiovascular and Pulmonary Diseases,Annual Reportsin Medicinal Chemistry, 33 (1998) pp. 91-101.
Souness, et al. “Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors”, Immunopharmacology, 47, (2000), pp. 127-162.
Dyke, et al., “The therapeutic potential of PDE4 inhibitors”,Exp. Opin. Invest. Drugs(1999) 8(9): 1301-1325.
Norman, Peter, “PDE4 Inhibitors 1999”,Exp. Opin. Ther. Patents, (1999) 9 (8) :1101-1118.

Affiliated with

Also associated with

Rating

Compounds effective as &#x3b2;2-adrenoreceptor agonists as... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds effective as &#x3b2;2-adrenoreceptor agonists as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds effective as &#x3b2;2-adrenoreceptor agonists as... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3480466